1st Quarter - Termination
IMPACT HEALTH POLICY PARTNERS for HEPATITIS B FOUNDATION
Client
Income
$10,000
Expenses
—
Terminated
Mar 1, 2025
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Provide efforts to increase research to control and cure hepatitis B and other infectious diseases on behalf of the Hepatitis B Foundation and its nonprofit affiliates (Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center). Issues related to Federal Community Project Funding via the FY2025 and FY2026 budget and appropriations process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALYSON LEWIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.